| ²é¿´: 238 | »Ø¸´: 1 | |||
ͻͻö©ö©½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
20½ð±ÒÇó΢Æ×²éѯһ×é̼Æ×Êý¾Ý
|
| 14.0, 22.5, 24.6, 25.1, 25.7, 26.9, 27.3, 28.9, 29.0, 29.2, 31.9, 34.0, 37.0, 71.9, 80.8, 81.8, 108.5, 127.4, 137.8, 179.2 |
» ²ÂÄãϲ»¶
327Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
08¹¤¿ÆÇóµ÷¼Á290·Ö
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸985³õÊÔ354·ÖÉúÎïµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸2110£¬»¯Ñ§Ñ§Ë¶310·Ö£¬±¾¿ÆÖصãË«·ÇÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
353Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
334Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
Ò»Ö¾Ô¸0807 ÊýÒ»Ó¢Ò» 313 ÓÐûÓжþÂÖµ÷¼Á
ÒѾÓÐ7È˻ظ´
¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤289·Ö
ÒѾÓÐ14È˻ظ´
086000µ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú΢Æ×Êý¾Ý¿â
ÒѾÓÐ7È˻ظ´
°ïæ²éÏÂ΢Æ×Êý¾Ý£¬½ð±ÒºÃÉÌÁ¿£¡
ÒѾÓÐ3È˻ظ´
ÇóÖúÈý¸ö»¯ºÏÎ̼Æ×£©µÄ΢Æ×Êý¾Ý¿â¼ìË÷½á¹û£¨ÏàËÆ¶Èǰ20%£©
ÒѾÓÐ3È˻ظ´
Çó4¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý¿â²éѯ£¨50½ð±Ò£©
ÒѾÓÐ6È˻ظ´
ÇóÖú΢Æ×̼Æ×²éѯ
ÒѾÓÐ3È˻ظ´
Á½¸öÈýÝÆÀ໯ºÏÎï΢Æ×̼Æ×Êý¾Ý²éѯ
ÒѾÓÐ9È˻ظ´
ÇóÖú ²éѯάÆÕÊý¾Ý¡£¡£¡£¡£¡£¼±¼±¼± ÔÚÏߵȡ£¡£¡£¡£¡£×·¼Ó½ð±Ò¡£¡£¡£
ÒѾÓÐ10È˻ظ´
¹òÇóÄÜÓÃ΢Æ×Êý¾Ý¿âµÄ³æ×ÓÃÇ£¬°ïæ²éÒ»ÏÂ̼Æ×Êý¾Ý£¬±¾ÈËËÍ6¸ö½ð±Ò£¡£¡£¡
ÒѾÓÐ7È˻ظ´
Âé·³ÓÐ΢Æ××ÊÔ´µÄ´ó¸ç´ó½ã°ïæ²é¸ö̼Æ×
ÒѾÓÐ4È˻ظ´
¸÷λ ËÄÄÀïÓÐ̼Æ×Êý¾Ý¿â£¿ÕýÔÚÊÔÓÃÆÚµÄ΢Æ×Êý¾ÝÒ²¿ÉÒÔ
ÒѾÓÐ6È˻ظ´
»ªÖпƼ¼´óѧµÄ³æÓÑÇë×¢Ò⣡΢Æ×ºË´Å¹²Õñ̼Æ×Êý¾Ý¿âÔÚ»ªÖпƼ¼´óѧÊÔÓã¡
ÒѾÓÐ13È˻ظ´
¡¾·ÖÏí¡¿À¼ÖÝ´óѧ£¬ÄϾ©ÖÐÒ½Ò©´óѧµÄ³æÓÑÇë×¢Ò⣡΢Æ×NMR̼Æ×¿âÊÔÓ㬻¶Ó·ÃÎÊ
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿¸ß½ðÎÊÒ»×é̼Æ×Êý¾ÝµÄĸºË½á¹¹¡£
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿20½ð±ÒÇóÒ»¸ö΢»ý·Ö·½³Ì
ÒѾÓÐ15È˻ظ´
¡¾ÇóÖú¡¿20½ð±ÒÇóÖúÑ»··ü°²·¨²â΢Èé½á¹¹ÊµÑé²½Ö裬¼±~~~
ÒѾÓÐ4È˻ظ´
nkx1979
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 151 (¸ßÖÐÉú)
- ½ð±Ò: 2074
- É¢½ð: 20
- ºì»¨: 3
- Ìû×Ó: 953
- ÔÚÏß: 64.3Сʱ
- ³æºÅ: 2111800
- ×¢²á: 2012-11-07
- רҵ: ÌìȻҩÎﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ͻͻö©ö©: ½ð±Ò+20 2013-04-16 18:27:04
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ͻͻö©ö©: ½ð±Ò+20 2013-04-16 18:27:04
|
1 . [1S-[1¦Á,2¦Á(Z),3¦Á(S*),4¦Á]]-7-[3-[(2-Heptylthio)methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic Acid C21H36O3S ÏàËÆ¶È:71.4% Journal of Medicinal Chemistry 1989 32 974-984 9,11-Epoxy-9-homo-14-thiaprost-5-enoic acid derivatives: potent thromboxane A2 antagonists Steven E. Hall, Wen Ching Han, Don N. Harris, Anders Hedberg, Martin L. Ogletree Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 2 . (4S,5S)-2,2-Dimethyl-4-formyl-5-[(E)-dodec-1-enyl]-1,3-dioxolane C18H32O3 ÏàËÆ¶È:70% Journal of the Chemical Society, Perkin Transactions 1 1997 1013-1016 D-Erythronolactone as a C4 building unit. Part 2.1 A short and efficient synthesis of both enantiomers of epi-muricatacin, a diastereoisomer of the native acetogenin from Annona muricata Andreas Gypser, Marcus Peterek and Hans-Dieter Scharf Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 3 . (9Z,11E)-13-hydroxy-9,11-octadecadienoic acid C18H32O3 ÏàËÆ¶È:70% Bioscience, Biotechnology, and Biochemistry 2000 64 882-886 (10E,12Z,15Z)-9-Hydroxy-10,12,15-octadecatrienoic Acid Methyl Ester as an Anti-inflammatory Compound from Ehretia dicksonii Mei DONG, Yukiko ODA, Mitsuru HIROTA Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 4 . (2S,5S)-2-[1-(tert-butyldiphenylsilyl)oxymethyl]-5-[(1R)-(1-hydroxy)decyl]tetrahydrofuran C32H50O3Si ÏàËÆ¶È:70% Heterocycles 2000 53 1361-1370 Stereoselective Synthesis of the 3-Hydroxytetrahydropyran Part of Mucocin, an Antitumor Agent, Based on Rearrangement-Ring Expansion Reaction of a Tetrahydrofuran Derivative Shunya Takahashi, Kenji Fujisawa, Nobuo Sakairi, and Tadashi Nakata* Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 5 . (9S,10E,12Z)-9-Hydroxy-10,12-octadecadienoic Acid C18H32O3 ÏàËÆ¶È:70% Journal of Agricultural and Food Chemistry 2008 56 5062-5068 Isolation and Identification of Antifungal Fatty Acids from the Basidiomycete Gomphus floccosus Charles L. Cantrell, Bethany P. Case, E. Edward Mena, Toby M. Kniffin, Stephen O. Duke and David E. Wedge Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 6 . [1S-(1¦Á,2¦Á(5Z),3¦Á(1E,3S*),4¦Á)]-7-[3-(3-Hyroxy-l-octenyl)-7-oxabicyclo[2.2.1]heptan-2-yl]-5-heptenoic Acid C21H34O4 ÏàËÆ¶È:70% Journal of Medicinal Chemistry 1985 28 1580-1590 Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogs of thromboxane A2/PGH2 P. W. Sprague, J. E. Heikes, J. Z. Gougoutas, M. F. Malley, D. N. Harris, R. Greenberg Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 7 . [1R-[1¦Á,2¦Â(Z),3¦Â,4¦Á]]-7-[3-[(Hexyloxy)methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic Acid C20H34O4 ÏàËÆ¶È:70% Journal of Medicinal Chemistry 1986 29 2335-2347 9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenase Steven E. Hall, Wen Ching Han, Martin F. Haslanger, Don N. Harris, Martin L. Ogletree Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 8 . 9, 10-O-isopropyllidene-(12 Z)-en-octadecaoic acid C21H38O4 ÏàËÆ¶È:66.6% Acta Botanica Yunnanica 2007 29(5) 586-590 Chemical Investigation of Sulcaria virens (Alectoriaceae) ZHOU Zhong-Yu, WANGLi-Song,WANG Fei, LIU Ji-Kai Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 9 . (R)-1-((4R,5R)-5-(5-(benzyloxy)pentyl)-2,2-dimethyl-1,3-dioxolan-4-yl)non-3-yn-1-ol C26H40O4 ÏàËÆ¶È:66.6% Tetrahedron 2013 69 1881-1896 Metal-mediated alkynediol cycloisomerization: first and second generation formal total syntheses of didemniserinolipid B Shyamsundar Das, Boddeti Induvadana, C.V. Ramana Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 10 . (R)-1-((4R,5R)-5-(5-(benzyloxy)pentyl)-2,2-dimethyl-1,3-dioxolan-4-yl)non-3-yn-1-ol C26H40O4 ÏàËÆ¶È:66.6% Tetrahedron 2013 69 1881-1896 Metal-mediated alkynediol cycloisomerization: first and second generation formal total syntheses of didemniserinolipid B Shyamsundar Das, Boddeti Induvadana, C.V. Ramana Structure 13C NMR ̼Æ×Ä£Äâͼ |

2Â¥2013-04-13 07:05:34













»Ø¸´´ËÂ¥